107 related articles for article (PubMed ID: 8592671)
1. A microcalorimetric investigation of the interaction of surfactants with crystalline and partially crystalline salbutamol sulphate in a model inhalation aerosol system.
Blackett PM; Buckton G
Pharm Res; 1995 Nov; 12(11):1689-93. PubMed ID: 8592671
[TBL] [Abstract][Full Text] [Related]
2. The distribution of oleic acid between salbutamol base drug and different propellant blends.
Eriksson PM; Sandström KB; Rosenholm JB
Pharm Res; 1995 May; 12(5):715-9. PubMed ID: 7479558
[TBL] [Abstract][Full Text] [Related]
3. Characterization of surfactant effect on aggregates in model aerosol propellent suspensions.
Bower C; Washington C; Purewal TS
J Pharm Pharmacol; 1996 Apr; 48(4):337-41. PubMed ID: 8794979
[TBL] [Abstract][Full Text] [Related]
4. Humidity-induced changes of the aerodynamic properties of dry powder aerosol formulations containing different carriers.
Zeng XM; MacRitchie HB; Marriott C; Martin GP
Int J Pharm; 2007 Mar; 333(1-2):45-55. PubMed ID: 17064863
[TBL] [Abstract][Full Text] [Related]
5. The effect of alkylpolyglycoside surfactants on the crystallization of spray-dried salbutamol sulphate: a GravimetricNear-Infrared Spectroscopy Study.
Columbano A; Buckton G; Wikeley P
AAPS PharmSci; 2002; 4(3):E16. PubMed ID: 12423065
[TBL] [Abstract][Full Text] [Related]
6. Influence of mechanical activation on the physical stability of salbutamol sulphate.
Brodka-Pfeiffer K; Langguth P; Grass P; Häusler H
Eur J Pharm Biopharm; 2003 Nov; 56(3):393-400. PubMed ID: 14602182
[TBL] [Abstract][Full Text] [Related]
7. A novel method for the production of crystalline micronised particles.
Muhammad SA; Langrish T; Tang P; Adi H; Chan HK; Kazarian SG; Dehghani F
Int J Pharm; 2010 Mar; 388(1-2):114-22. PubMed ID: 20043982
[TBL] [Abstract][Full Text] [Related]
8. Physicochemical and in vitro deposition properties of salbutamol sulphate/ipratropium bromide and salbutamol sulphate/excipient spray dried mixtures for use in dry powder inhalers.
Corrigan DO; Corrigan OI; Healy AM
Int J Pharm; 2006 Sep; 322(1-2):22-30. PubMed ID: 16815654
[TBL] [Abstract][Full Text] [Related]
9. Effect of crystallisation conditions and feedstock morphology on the aerosolization performance of micronised salbutamol sulphate.
Shariare MH; de Matas M; York P
Int J Pharm; 2011 Aug; 415(1-2):62-72. PubMed ID: 21683128
[TBL] [Abstract][Full Text] [Related]
10. Use of heat of adsorption to quantify amorphous content in milled pharmaceutical powders.
Alam S; Omar M; Gaisford S
Int J Pharm; 2014 Jan; 459(1-2):19-22. PubMed ID: 24315924
[TBL] [Abstract][Full Text] [Related]
11. Influence of small amorphous amounts in hydrophilic and hydrophobic APIs on storage stability of dry powder inhalation products.
Müller T; Krehl R; Schiewe J; Weiler C; Steckel H
Eur J Pharm Biopharm; 2015 May; 92():130-8. PubMed ID: 25769680
[TBL] [Abstract][Full Text] [Related]
12. Electrophoretic mobility of salbutamol drug powder in mixed propellant solvents.
Sandström KB; Eriksson PM; Rosenholm JB
J Pharm Sci; 1994 Oct; 83(10):1380-5. PubMed ID: 7884654
[TBL] [Abstract][Full Text] [Related]
13. Isothermal calorimetry: a predictive tool to model drug-propellant interactions in pressurized metered dose systems.
Ooi J; Gaisford S; Boyd BJ; Young PM; Traini D
Int J Pharm; 2014 Jan; 461(1-2):301-9. PubMed ID: 24325938
[TBL] [Abstract][Full Text] [Related]
14. Process-induced crystallinity changes in albuterol sulfate and its effect on powder physical stability.
Ward GH; Schultz RK
Pharm Res; 1995 May; 12(5):773-9. PubMed ID: 7479567
[TBL] [Abstract][Full Text] [Related]
15. How does secondary processing affect the physicochemical properties of inhalable salbutamol sulphate particles? A temporal investigation.
Pinto JT; Radivojev S; Zellnitz S; Roblegg E; Paudel A
Int J Pharm; 2017 Aug; 528(1-2):416-428. PubMed ID: 28619456
[TBL] [Abstract][Full Text] [Related]
16. A study of the crystallisation of amorphous salbutamol sulphate using water vapour sorption and near infrared spectroscopy.
Columbano A; Buckton G; Wikeley P
Int J Pharm; 2002 Apr; 237(1-2):171-8. PubMed ID: 11955815
[TBL] [Abstract][Full Text] [Related]
17. Following mechanical activation of salbutamol sulphate during ball-milling with isothermal calorimetry.
Gaisford S; Dennison M; Tawfik M; Jones MD
Int J Pharm; 2010 Jun; 393(1-2):74-8. PubMed ID: 20385222
[TBL] [Abstract][Full Text] [Related]
18. Preparation of inhalable salbutamol sulphate using reactive high gravity controlled precipitation.
Hu T; Chiou H; Chan HK; Chen JF; Yun J
J Pharm Sci; 2008 Feb; 97(2):944-9. PubMed ID: 17722000
[TBL] [Abstract][Full Text] [Related]
19. In vitro investigation of drug particulates interactions and aerosol performance of pressurised metered dose inhalers.
Traini D; Young PM; Rogueda P; Price R
Pharm Res; 2007 Jan; 24(1):125-35. PubMed ID: 17103336
[TBL] [Abstract][Full Text] [Related]
20. The effect of surfactant and solid phase concentration on drug aggregates in model aerosol propellent suspensions.
Bower C; Washington C; Purewal TS
J Pharm Pharmacol; 1996 Apr; 48(4):342-6. PubMed ID: 8794980
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
